The Efficacy of Baricitinib Plus Remdesivir Compared to Dexamethasone Plus Remdesivir in Hospitalised COVID-19 Patients With Diabetes Mellitus
Latest Information Update: 08 May 2024
At a glance
- Drugs Baricitinib (Primary) ; Remdesivir (Primary) ; Dexamethasone
- Indications COVID-19 pneumonia; SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- 07 Apr 2024 Status changed from recruiting to withdrawn prior to enrolment. (adequate cases were not available )
- 27 Jul 2021 New trial record